174 related articles for article (PubMed ID: 12540846)
1. The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein.
Kalant D; Cain SA; Maslowska M; Sniderman AD; Cianflone K; Monk PN
J Biol Chem; 2003 Mar; 278(13):11123-9. PubMed ID: 12540846
[TBL] [Abstract][Full Text] [Related]
2. The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74).
Cain SA; Monk PN
J Biol Chem; 2002 Mar; 277(9):7165-9. PubMed ID: 11773063
[TBL] [Abstract][Full Text] [Related]
3. C5L2 is a functional receptor for acylation-stimulating protein.
Kalant D; MacLaren R; Cui W; Samanta R; Monk PN; Laporte SA; Cianflone K
J Biol Chem; 2005 Jun; 280(25):23936-44. PubMed ID: 15833747
[TBL] [Abstract][Full Text] [Related]
4. Ligand specificity of the anaphylatoxin C5L2 receptor and its regulation on myeloid and epithelial cell lines.
Johswich K; Martin M; Thalmann J; Rheinheimer C; Monk PN; Klos A
J Biol Chem; 2006 Dec; 281(51):39088-95. PubMed ID: 17068344
[TBL] [Abstract][Full Text] [Related]
5. Recombinant C3adesArg/acylation stimulating protein (ASP) is highly bioactive: a critical evaluation of C5L2 binding and 3T3-L1 adipocyte activation.
Cui W; Lapointe M; Gauvreau D; Kalant D; Cianflone K
Mol Immunol; 2009 Oct; 46(16):3207-17. PubMed ID: 19767107
[TBL] [Abstract][Full Text] [Related]
6. C5L2, a nonsignaling C5A binding protein.
Okinaga S; Slattery D; Humbles A; Zsengeller Z; Morteau O; Kinrade MB; Brodbeck RM; Krause JE; Choe HR; Gerard NP; Gerard C
Biochemistry; 2003 Aug; 42(31):9406-15. PubMed ID: 12899627
[TBL] [Abstract][Full Text] [Related]
7. The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding.
Scola AM; Higginbottom A; Partridge LJ; Reid RC; Woodruff T; Taylor SM; Fairlie DP; Monk PN
J Biol Chem; 2007 Feb; 282(6):3664-71. PubMed ID: 17158873
[TBL] [Abstract][Full Text] [Related]
8. C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a.
Chen NJ; Mirtsos C; Suh D; Lu YC; Lin WJ; McKerlie C; Lee T; Baribault H; Tian H; Yeh WC
Nature; 2007 Mar; 446(7132):203-7. PubMed ID: 17322907
[TBL] [Abstract][Full Text] [Related]
9. C5L2 and C5aR interaction in adipocytes and macrophages: insights into adipoimmunology.
Poursharifi P; Lapointe M; Pétrin D; Devost D; Gauvreau D; Hébert TE; Cianflone K
Cell Signal; 2013 Apr; 25(4):910-8. PubMed ID: 23268185
[TBL] [Abstract][Full Text] [Related]
10. C5a- and ASP-mediated C5L2 activation, endocytosis and recycling are lost in S323I-C5L2 mutation.
Cui W; Simaan M; Laporte S; Lodge R; Cianflone K
Mol Immunol; 2009 Sep; 46(15):3086-98. PubMed ID: 19615750
[TBL] [Abstract][Full Text] [Related]
11. C5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2: position 69 is the locus that determines agonism or antagonism.
Otto M; Hawlisch H; Monk PN; Müller M; Klos A; Karp CL; Köhl J
J Biol Chem; 2004 Jan; 279(1):142-51. PubMed ID: 14570896
[TBL] [Abstract][Full Text] [Related]
12. Acylation-stimulating protein/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo.
Cui W; Paglialunga S; Kalant D; Lu H; Roy C; Laplante M; Deshaies Y; Cianflone K
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1482-91. PubMed ID: 17711993
[TBL] [Abstract][Full Text] [Related]
13. The ASP receptor C5L2 is regulated by metabolic hormones associated with insulin resistance.
MacLaren R; Kalant D; Cianflone K
Biochem Cell Biol; 2007 Feb; 85(1):11-21. PubMed ID: 17464341
[TBL] [Abstract][Full Text] [Related]
14. C5aR and C5L2 act in concert to balance immunometabolism in adipose tissue.
Poursharifi P; Lapointe M; Fisette A; Lu H; Roy C; Munkonda MN; Fairlie DP; Cianflone K
Mol Cell Endocrinol; 2014 Jan; 382(1):325-333. PubMed ID: 24397921
[TBL] [Abstract][Full Text] [Related]
15. [Role of progesterone in acylation stimulating protein-receptor C5L2 pathway in adipocytes and preadipocytes].
Wen Y; Wang HW; Hu XF; Cianflone K; Wei J; Xia Z; Li RZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):114-8. PubMed ID: 18353218
[TBL] [Abstract][Full Text] [Related]
16. The human complement fragment receptor, C5L2, is a recycling decoy receptor.
Scola AM; Johswich KO; Morgan BP; Klos A; Monk PN
Mol Immunol; 2009 Mar; 46(6):1149-62. PubMed ID: 19100624
[TBL] [Abstract][Full Text] [Related]
17. C5a-stimulated recruitment of beta-arrestin2 to the nonsignaling 7-transmembrane decoy receptor C5L2.
Van Lith LH; Oosterom J; Van Elsas A; Zaman GJ
J Biomol Screen; 2009 Oct; 14(9):1067-75. PubMed ID: 19641221
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning and characterization of the human anaphylatoxin C3a receptor.
Ames RS; Li Y; Sarau HM; Nuthulaganti P; Foley JJ; Ellis C; Zeng Z; Su K; Jurewicz AJ; Hertzberg RP; Bergsma DJ; Kumar C
J Biol Chem; 1996 Aug; 271(34):20231-4. PubMed ID: 8702752
[TBL] [Abstract][Full Text] [Related]
19. Complement C5a receptors in the pituitary gland: expression and function.
Francis K; Lewis BM; Monk PN; Ham J
J Endocrinol; 2008 Dec; 199(3):417-24. PubMed ID: 19020281
[TBL] [Abstract][Full Text] [Related]
20. C5L2: a controversial receptor of complement anaphylatoxin, C5a.
Li R; Coulthard LG; Wu MC; Taylor SM; Woodruff TM
FASEB J; 2013 Mar; 27(3):855-64. PubMed ID: 23239822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]